Fairvalue-Calculator Fairvalue-Calculator
EN DE

TRGU (TRGU) Fair Value & Analysis

Consumer Defensive · ID · Market cap 1.4T IDR

Price173.00 IDR
Fair Value42.35 IDR
Upside-75.5%
Quality95/100
Evidence: High Range 18.79 IDR – 123.55 IDR

Fair value as of: Jun 24, 2026

Analysis

TRGU (TRGU) currently trades at 173.00 IDR, while our model-based Fair Value estimate is 42.35 IDR — implying the stock looks roughly 75.5% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

PT Cerestar Indonesia Tbk production of processed wheat flour products in Indonesia. It operates through Flour and grain processing and Others. The company was founded in 2020 and is based in Jakarta Pusat, Indonesia. PT Cerestar Indonesia Tbk operates as a subsidiary of PT Sunterra Indonesia.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is TRGU (TRGU) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 42.35 IDR versus a price of 173.00 IDR — about −76% (overvalued). Model-based estimate, not financial advice.
What is the fair value of TRGU?
Our 21-model fair value for TRGU is 42.35 IDR (as of Jun 24, 2026), built from audited fundamentals. The current price is 173.00 IDR.
What is the quality score of TRGU?
TRGU has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.